# Intero Biosystems Wants Drugmakers to Test on Mini Human Intestines, Not Animals

> **Platform:** [SPIDITS AI](https://spidits.com/) — Real-Time AI News & Market Intelligence  
> **Published:** 2026-10-14T12:00:00.000Z  
> **Category:** PRODUCT_LAUNCH  
> **Impact Score:** 90/100  
> **Primary Source:** [TechCrunch Startups](https://techcrunch.com/2026/10/14/intero-biosystems-wants-drugmakers-to-test-on-mini-human-intestines-not-animals)  
> **Canonical Citation:** [https://spidits.com/timeline/intero-biosystems-wants-drugmakers-to-test-on-mini-human-intestines-not](https://spidits.com/timeline/intero-biosystems-wants-drugmakers-to-test-on-mini-human-intestines-not)

## Executive Summary
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale.

## Why It Matters (Strategic Analysis)
The commercial deployment of multi-cell human intestinal organoids addresses high clinical trial failure rates caused by cross-species physiological discrepancies in animal testing. Providing living tissue models that mimic complex human gut biology enables more accurate preclinical toxicity screening and disease response evaluation.

## Referenced Coverage & Sources
- **[TechCrunch Startups](https://techcrunch.com/2026/10/14/intero-biosystems-wants-drugmakers-to-test-on-mini-human-intestines-not-animals)**: Intero Biosystems wants drugmakers to test on mini human intestines, not animals — _Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale..._

---
*Synthesized by SPIDITS AI Market Intelligence Desk. Track live AI news, model releases, and funding: [https://spidits.com](https://spidits.com)*